Dyadic Logo Current.jpg
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
March 14, 2024 16:30 ET | Dyadic International, Inc.
JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused building...
22157.jpg
Global Syndromic Multiplex Panels Market Set for Rapid Expansion, Reveals New 2024-2028 Sector Forecast
March 12, 2024 11:23 ET | Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country....
Industry Orgs Applau
Industry Orgs Applaud Bill to Boost Bars, Restaurants and Venues with Draft Systems
March 11, 2024 14:21 ET | Beer Institute
WASHINGTON, March 11, 2024 (GLOBE NEWSWIRE) -- Today, the Beer Institute, the oldest national trade association representing the beer industry, released the following statement after Reps. Darin...
Asia-Pacific Next-Generation IVD Market
Asia-Pacific's Next-Generation IVD Market Worth $42+ Billion by 2033: Key Insights by Type, End-user and Country
March 08, 2024 10:04 ET | Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Next-Generation IVD Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The...
US Medical Diagnostics Market
United States Medical Diagnostics Analysis Report 2024-2028: Growing Burden of Chronic Diseases, Escalating Use of EHR Systems and Rising Healthcare Expenditure Driving Growth
March 07, 2024 05:51 ET | Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has...
European Medical Diagnostics Market
Europe Medical Diagnostics Analysis Report 2024: A $109.91 Billion Market by 2028 with Focus on Immunoassays, Clinical Chemistry, Haematology & Coagulation
March 07, 2024 05:20 ET | Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Europe Medical Diagnostics Market (Immunoassays, Clinical Chemistry, Haematology & Coagulation): Insights & Forecast with Potential Impact of...
22157.jpg
Global COVID-19 Diagnostics Market Research Report 2024
February 29, 2024 04:40 ET | Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global COVID-19 Diagnostics Market Forecast by Technology, Product, Channel and Country: Assay Volumes and 5-Year Market Size Outlook" report has been...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
February 27, 2024 15:52 ET | BioAegis Therapeutics
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
22157.jpg
Infectious Disease Diagnostics Market Analysis Reveals Surge in DTC Testing Approaches amid COVID-19
February 23, 2024 06:32 ET | Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market...
Dyadic Logo Current.jpg
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
February 21, 2024 08:30 ET | Dyadic International, Inc.
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced...